investor.jnj.comInvestor Relations | Johnson & Johnson

Investor Relations | Johnson & Johnson Overview Investor fact sheet News Pipeline Pharmaceutical pipeline Development pipeline Novel therapies 2024 Key events Patent table Financials Quarterly results Annual reports SEC filings Events & presentations Stock info Stock quote Stock chart Historical stock quote Investment calculator Dividend history Stock split information Governance Corporate governance overview 2024 Annual Meeting of Shareholders Board of Directors Executive Committee ESG resources 2022 Health for Humanity Report 2022 Janssen Transparency Report Resources Investor FAQs Information request form Investor email alerts Investor contacts Go to jnj.com Investor RelationsLatest news Our company Careers Investors Media centerInvestor OverviewEnterprise Business ReviewLearn MoreOverview Investor fact sheet News Pipeline Pharmaceutical pipeline Development pipeline Novel therapies 2024 Key events Patent table Financials Quarterly results Annual reports SEC filings Events & presentations Stock info Stock quote Stock chart Historical stock quote Investment calculator Dividend history Stock split information Governance Corporate governance overview 2024 Annual Meeting of Shareholders Board of Directors Executive Committee ESG resources 2022 Health for Humanity Report 2022 Janssen Transparency Report Resources Investor FAQs Information request form Investor email alerts Investor contacts Go to jnj.com The J&J value As the world’s largest, most diversified healthcare products company, we are committed to using our reach and size for good.At Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal. About Johnson & Johnson Delivering long-term value for our stakeholders 60 Consecutive years of dividend increases 60% 5-Year free cash flow returned to shareholders 65% Of sales come from #1 or #2 global market share position 2023 Investor fact sheet Investor news See all investor news Events and presentations See all investor events Learn more Pharmaceutical pipeline Learn more Environmental, social, and governance Learn more Information on tax basis following Kenvue separation Contact Investor RelationsQuestions? Please contact us: 1-800-950-5089 [email protected] Do Not Sell or Share My Personal Information Limit the Use of My Sensitive Personal InformationLeadership Team Office of The Chief Medical Officer Announcements Media Center OUR COMMITMENTS Code of Business Conduct Environment, Social, Governance Sustainability GET IN TOUCH Contact Us Follow us on Youtube Follow us on Facebook Follow us on InstagramFollow us on Twitter Follow us on LinkedIn Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Johnson & Johnson, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Johnson & Johnson to send you the requested Investor Email Alert updates. * Required Email address * Investor alert options Investor alert options * News Quarterly reports Annual reports SEC filings End of day stock quote Events & presentations Unsubscribe Email Alert Sign Up Confirmation This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy . Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy . Your use of the information on this site is subject to the terms of our Legal Notice . You should view the News section and the most recent SEC Filings in the Investor sectionin order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information. © Johnson & Johnson Services, Inc. Careers Investors Privacy Policy Terms of Use Customize Cookie Settings Powered By Q4 Inc. 5.122.0.3 (opens in new...